180
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Impact of prenatal tramadol exposure on cerebral and cerebellar development and amyloid precursor protein expression in newborn mice

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 310-324 | Received 21 Jan 2024, Accepted 11 May 2024, Published online: 08 Jun 2024

References

  • Ahmadimanesh, M., Naeini, M. B., Rouini, M. R., Shadnia, S., & Ghazi-Khansari, M. (2020). Assessment of tramadol pharmacokinetics in correlation with CYP2D6 and clinical symptoms. Drug Metabolism and Personalized Therapy, 35(2), 1–10. doi:10.1515/dmpt-2019-0021
  • Arai, Y., Iwasaki, Y., Suzuki, T., Ide, S., & Kaga, M. (2019). Elimination of amyloid precursor protein in senile plaques in the brain of a patient with Alzheimer-type dementia and down syndrome. Brain & Development, 41(1), 106–110. doi:10.1016/j.braindev.2018.07.017
  • Asahi, H., Inoue, S.-I., Niikura, M., Kunigo, K., Suzuki, Y., Kobayashi, F., & Sendo, F. (2017). Profiling molecular factors associated with pyknosis and developmental arrest induced by an opioid receptor antagonist and dihydroartemisinin in Plasmodium falciparum. PLOS One, 12(9), e0184874. doi:10.1371/journal.pone.0184874
  • Bai, J., Ye, T., Wei, Y. B., Yang, Y., Yang, H. M., & Lan, Y. (2022). Opioid receptors modulate parallel fiber-Purkinje cell synaptic transmission in mouse cerebellum. Neuroscience Letters, 770, 136356. doi:10.1016/j.neulet.2021.136356
  • Bancroft, J. D., & Layton, C. (2013). 10 - The hematoxylins and eosin. In S. K. Suvarna, C. Layton, & J. D. Bancroft (Eds.), Bancroft’s Theory and Practice of Histological Techniques (Seventh Edition) (pp. 173–186). Oxford: Churchill Livingstone.
  • Brendel, M., Delker, A., Rötzer, C., Böning, G., Carlsen, J., Cyran, C., … Rominger, A. (2014). Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET. NeuroImage, 84, 843–853. doi:10.1016/j.neuroimage.2013.09.017
  • Bateman, B. T., Hernandez-Diaz, S., Straub, L., Zhu, Y., Gray, K. J., Desai, R. J., … Huybrechts, K. F. (2021). Association of first trimester prescription opioid use with congenital malformations in the offspring: Population based cohort study. BMJ, 372, n102. doi:10.1136/bmj.n102
  • Cai, W., Li, L., Sang, S., Pan, X., & Zhong, C. (2023). Physiological roles of β-amyloid in regulating synaptic function: Implications for AD pathophysiology. Neuroscience Bulletin, 39(8), 1289–1308. doi:10.1007/s12264-022-00985-9
  • Chwalisz, B. K. (2021). Cerebral amyloid angiopathy and related inflammatory disorders. Journal of the Neurological Sciences, 424, 117425. doi:10.1016/j.jns.2021.117425
  • Corbett, K., Dugan, A., Vitale, C., & Gravel, T. (2019). Long-term effects of opioids on the cardiovascular system: Examine the evidence. Nursing, 49(4), 47–49. doi:10.1097/01.Nurse.0000554247.12754.28
  • Couly, S., Goguadze, N., Yasui, Y., Kimura, Y., Wang, S.-M., Sharikadze, N., … Su, T.-P. (2022). Knocking out sigma-1 receptors reveals diverse health problems. Cellular and Molecular Neurobiology, 42(3), 597–620. doi:10.1007/s10571-020-00983-3
  • Dar, N. J., & Glazner, G. W. (2020). Deciphering the neuroprotective and neurogenic potential of soluble amyloid precursor protein alpha (sAPPα). Cellular and Molecular Life Sciences, 77(12), 2315–2330. doi:10.1007/s00018-019-03404-x
  • Dave, C. V., Goodin, A., Zhu, Y., Winterstein, A., Wang, X., Alrwisan, A., & Hartzema, A. (2019). Prevalence of maternal-risk factors related to neonatal abstinence syndrome in a commercial claims database: 2011-2015. Pharmacotherapy, 39(10), 1005–1011. doi:10.1002/phar.2315
  • Dhesi, M., & Maldonado, K. A, CV, M. (2023). & Tramadol: Stat Pearls Publishing, FL, USA.
  • Edinoff, A. N., Kaplan, L. A., Khan, S., Petersen, M., Sauce, E., Causey, C. D., … Kaye, A. D. (2021). Full opioid agonists and tramadol: Pharmacological and clinical considerations. Anesthesiology and Pain Medicine, 11(4), e119156. doi:10.5812/aapm.119156
  • Els, C., Jackson, T. D., Kunyk, D., Lappi, V. G., Sonnenberg, B., Hagtvedt, R., … Straube, S. (2017). Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: An overview of cochrane reviews. The Cochrane Database of Systematic Reviews, 10(10), Cd012509. doi:10.1002/14651858.CD012509.pub2
  • Fishman, B., Daniel, S., Koren, G., Lunenfeld, E., & Levy, A. (2019). Pregnancy outcome following opioid exposure: A cohort study. PLOS One, 14(7), e0219061. doi:10.1371/journal.pone.0219061
  • Ghoneim, F. M., Khalaf, H. A., Elsamanoudy, A. Z., & Helaly, A. N. (2014). Effect of chronic usage of tramadol on motor cerebral cortex and testicular tissues of adult male albino rats and the effect of its withdrawal: Histological, immunohistochemical and biochemical study. International Journal of Clinical and Experimental Pathology, 7(11), 7323–7341.
  • Grond, S., & Sablotzki, A. (2004). Clinical pharmacology of tramadol. Clinical Pharmacokinetics, 43(13), 879–923. doi:10.2165/00003088-200443130-00004
  • Guedes-Dias, P., & Holzbaur, E. L. F. (2019). Axonal transport: Driving synaptic function. Science, 366(6462), 1–35. doi:10.1126/science.aaw9997
  • Guo, Q., Li, H., Gaddam, S. S., Justice, N. J., Robertson, C. S., & Zheng, H. (2012). Amyloid precursor protein revisited: Neuron-specific expression and highly stable nature of soluble derivatives. The Journal of Biological Chemistry, 287(4), 2437–2445. doi:10.1074/jbc.M111.315051
  • Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012). Trafficking and proteolytic processing of APP. Cold Spring Harbor Perspectives in Medicine, 2(5), a006270–a006270. doi:10.1101/cshperspect.a006270
  • Hamina, A., Lavikainen, P., Tanskanen, A., Tolppanen, A. M., Tiihonen, J., Hartikainen, S., & Taipale, H. (2018). Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer’s disease. International Psychogeriatrics, 30(7), 947–956. doi:10.1017/s1041610217002897
  • Hick, M., Herrmann, U., Weyer, S. W., Mallm, J.-P., Tschäpe, J.-A., Borgers, M., … Müller, U. C. (2015). Acute function of secreted amyloid precursor protein fragment APPsα in synaptic plasticity. Acta Neuropathologica, 129(1), 21–37. doi:10.1007/s00401-014-1368-x
  • Horobin, R. W. (2013). 9 - How histological stains work. In S. K. Suvarna, C. Layton, & J. D. Bancroft (Eds.), Bancroft’s Theory and Practice of Histological Techniques (Seventh Edition) (pp. 157–171). Oxford: Churchill Livingstone.
  • Le Bras, A. (2021). New insights into the APP family. Lab Animal, 50(7), 166. doi:10.1038/s41684-021-00803-1
  • Liu, L., Lauro, B. M., Wolfe, M. S., & Selkoe, D. J. (2021). Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate γ-secretase function in generating Alzheimer-causing Aβ peptides. The Journal of Biological Chemistry, 296, 100393. doi:10.1016/j.jbc.2021.100393
  • Mochida, G. H., Poduri, A., & Walsh, C. A. (2013). Chapter 115 - genetic disorders of cerebral cortical development. In D. Rimoin, R. Pyeritz, & B. Korf (Eds.), Emery and Rimoin’s Principles and Practice of Medical Genetics (Sixth Edition) (pp. 1–26). Oxford: Academic Press.
  • Nguyen, K. V. (2019). β-Amyloid precursor protein (APP) and the human diseases. AIMS Neuroscience, 6(4), 273–281. doi:10.3934/Neuroscience.2019.4.273
  • O'Brien, R. J., & Wong, P. C. (2011). Amyloid precursor protein processing and Alzheimer’s disease. Annual Review of Neuroscience, 34(1), 185–204. doi:10.1146/annurev-neuro-061010-113613
  • Peng, Z., Bedi, S., Mann, V., Sundaresan, A., Homma, K., Gaskey, G., … Doursout, M.-F. (2021). Neuroprotective effects of asparagus officinalis stem extract in transgenic mice overexpressing amyloid precursor protein. Journal of Immunology Research, 2021, 8121407–8121410. doi:10.1155/2021/8121407
  • Perry, C., Chung, J.-Y., Ylaya, K., Choi, C. H., Simpson, A., Matsumoto, K. T., … Hewitt, S. M. (2016). A buffered alcohol-based fixative for histomorphologic and molecular applications. The Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society, 64(7), 425–440. doi:10.1369/0022155416649579
  • Richter, M. C., Ludewig, S., Winschel, A., Abel, T., Bold, C., Salzburger, L. R., … Müller, U. C. (2018). Distinct in vivo roles of secreted APP ectodomain variants APPsα and APPsβ in regulation of spine density, synaptic plasticity, and cognition. The EMBO Journal, 37(11), 1–23. doi:10.15252/embj.201798335
  • Salarinasab, S., Salimi, L., Alidadiani, N., Shokrollahi, E., Arzhanga, P., Karbasforush, S., … Nikanfar, M. (2020). Interaction of opioid with insulin/IGFs signaling in Alzheimer’s disease. Journal of Molecular Neuroscience, 70(6), 819–834. doi:10.1007/s12031-020-01478-y
  • Shamsi Meymandi, M., & Keyhanfar, F. (2013). Assessment of the antinociceptive effects of pregabalin alone or in combination with morphine during acetic acid-induced writhing in mice. Pharmacology, Biochemistry, and Behavior, 110, 249–254. doi:10.1016/j.pbb.2013.07.021
  • Specialists, O. o T. I. (2021). Mother To Baby: Fact Sheets: Organization of Teratology Information Specialists (OTIS).
  • Sullivan, M. D., & Ballantyne, J. C. (2022). Understanding the risks of long-term opioid therapy for chronic pain. The American Journal of Psychiatry, 179(10), 696–698. doi:10.1176/appi.ajp.20220592
  • Szidonya, L., & Nickerson, J. P. (2023). Cerebral amyloid angiopathy. Radiologic Clinics of North America, 61(3), 551–562. doi:10.1016/j.rcl.2023.01.009
  • Taipale, H., Hamina, A., Lampela, P., Tanskanen, A., Tiihonen, J., Karttunen, N., … Hartikainen, S. (2018). Is Alzheimer’s disease associated with previous opioid use? Pain Medicine (19(11), 2115–2121. doi:10.1093/pm/pnx210
  • Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P., & Kroemer, G. (2019). The molecular machinery of regulated cell death. Cell Research, 29(5), 347–364. doi:10.1038/s41422-019-0164-5
  • Yazdy, M. M., Desai, R. J., & Brogly, S. B. (2015). Prescription opioids in pregnancy and birth outcomes: A review of the literature. Journal of Pediatric Genetics, 4(2), 56–70. doi:10.1055/s-0035-1556740
  • Zebala, J. A., Searle, S. L., Webster, L. R., Johnson, M. S., Schuler, A. D., Maeda, D. Y., & Kahn, S. J. (2019). Desmetramadol has the safety and analgesic profile of tramadol without its metabolic liabilities: consecutive randomized, double-blind, placebo- and active comparator-controlled trials. The Journal of Pain, 20(10), 1218–1235. doi:10.1016/j.jpain.2019.04.005
  • Zheng, H., & Koo, E. H. (2011). Biology and pathophysiology of the amyloid precursor protein. Molecular Neurodegeneration, 6(1), 27. doi:10.1186/1750-1326-6-27